[Inhibitory effect of dexamethasone on myeloid differentiation factor 88 and tumor necrosis factor-alpha expressions

Wen-jie Zhao1, Li-yan Xi, Li Ma

  • 1Department of Dermatology, Second Affiliated Hospital, Sun Yat-sen University, Guangzhou 510120, China. zhaowenjie1972@sohu.com

Abstract

Insights

Dexamethasone (DEX) inhibits the innate immune response of mouse macrophages to Penicillium marneffei (PM) by suppressing myeloid differentiation factor 88 (MyD88) and tumor necrosis factor-alpha (TNF-alpha) expression.

Area of Science:

  • Immunology
  • Microbiology
  • Pharmacology

Context:

  • The innate immune system is crucial for host defense against fungal infections.
  • Penicillium marneffei (PM) is an opportunistic fungal pathogen causing significant morbidity and mortality.
  • Glucocorticoids like dexamethasone (DEX) are potent anti-inflammatory agents with complex immunomodulatory effects.

Purpose:

  • To investigate the effect of dexamethasone (DEX) on myeloid differentiation factor 88 (MyD88) and tumor necrosis factor-alpha (TNF-alpha) expression in mouse peritoneal macrophages during innate immune response to Penicillium marneffei (PM).

Summary:

  • Mouse peritoneal macrophages were stimulated with heat-inactivated PM in the presence or absence of DEX.
  • Western blotting and real-time PCR were used to assess MyD88 protein and mRNA expression.
  • Enzyme-linked immunosorbent assay measured TNF-alpha levels in the supernatant.
  • Results showed DEX suppressed PM-induced TNF-alpha production.
  • DEX also inhibited the upregulation of MyD88 expression induced by PM stimulation.

Impact:

  • Dexamethasone's anti-inflammatory effect on PM-induced macrophage responses is linked to the inhibition of MyD88 expression.
  • This finding provides insights into the molecular mechanisms underlying glucocorticoid action in fungal infections.
  • Understanding these pathways could inform therapeutic strategies for managing PM infections.

Related Concept Videos